相关实验视频

Updated: Jun 19, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

细胞外囊泡和免疫系统功能:探索结直肠癌免疫疗法的新方法

Antonio Biondi¹, Marco Vacante², Roberta Catania¹

¹Department of General Surgery and Medical-Surgical Specialties, University of Catania, Via Santa Sofia 78, 95123 Catania, Italy.

|July 27, 2024

概括

细胞外囊泡 (EVs) 是癌症免疫疗法的免疫调节的关键,特别是结直肠癌 (CRC). 这些囊泡提供了新的治疗策略,以增强对瘤的免疫反应.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

细胞外囊泡 (EVs) 越来越多地被认为是它们在细胞间通信中的作用.
免疫细胞释放EV,这些EV携带着影响免疫反应的生物活性分子.
结肠直肠癌 (CRC) 在免疫治疗中存在挑战,原因是瘤异质性和免疫逃避.

研究的目的:

审查EVs在癌症免疫疗法免疫调节中的作用.
专注于EVs在结直肠癌 (CRC) 治疗中的应用.
探索基于EV的策略在克服治疗局限性的潜力.

主要方法:

关于细胞外囊泡 (EV) 和癌症免疫治疗的研究文献综述.
对EV生物发生,类型和功能的分析,特别是来自免疫细胞的EV.
检查EV与癌细胞的相互作用及其对抗瘤免疫力的影响.

主要成果:

电动汽车可以增强免疫反应,并具有抗瘤特性.
免疫细胞衍生的EV在调节瘤微环境中起着重要作用.
电动车在克服传统癌症治疗的局限性方面显示出潜力.

结论:

细胞外囊泡 (EVs) 是癌症免疫疗法的有前途的前沿,特别是在结直肠癌 (CRC) 中.
对基于电动汽车的策略的进一步研究可能会导致变革性的癌症治疗模式.
解决瘤异质性等挑战对于成功的基于EV的治疗开发至关重要.

关键词:

结肠直肠癌是什么意思细胞外囊泡中的细胞外囊泡.免疫疗法免疫疗法

更多相关视频

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Published on: September 1, 2023

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...